Correlation Between 4D Molecular and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on 4D Molecular and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Regeneron Pharmaceuticals.
Diversification Opportunities for 4D Molecular and Regeneron Pharmaceuticals
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between FDMT and Regeneron is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of 4D Molecular i.e., 4D Molecular and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between 4D Molecular and Regeneron Pharmaceuticals
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Regeneron Pharmaceuticals. In addition to that, 4D Molecular is 4.17 times more volatile than Regeneron Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest 74,280 in Regeneron Pharmaceuticals on November 28, 2024 and sell it today you would lose (1,933) from holding Regeneron Pharmaceuticals or give up 2.6% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 99.8% |
Values | Daily Returns |
4D Molecular Therapeutics vs. Regeneron Pharmaceuticals
Performance |
Timeline |
4D Molecular Therapeutics |
Regeneron Pharmaceuticals |
4D Molecular and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 4D Molecular and Regeneron Pharmaceuticals
The main advantage of trading using opposite 4D Molecular and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
CEOs Directory Screen CEOs from public companies around the world |